You have 9 free searches left this month | for more free features.

hormone-receptor positive breast cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Musculoskeletal Syndrome Trial in Minneapolis (CBD-dominant, THC dominant)

Recruiting
  • Musculoskeletal Syndrome
  • Minneapolis, Minnesota
    University of Minnesota
Jun 28, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Breast Cancer Trial in Boston (Acupuncture, Usual Care)

Active, not recruiting
  • Breast Cancer
  • Acupuncture
  • Usual Care
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 21, 2022

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 22, 2022

Hot Flashes, Breast Cancer, Acupuncture Trial in Nanjing (Acupuncture treatment, Sham acupuncture treatment)

Not yet recruiting
  • Hot Flashes
  • +2 more
  • Acupuncture treatment
  • Sham acupuncture treatment
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital of Traditional Chinese Medcine
Nov 11, 2022

Hot Flashes, Breast Cancer, Acupuncture Trial in Nanjing (Acupuncture treatment, Sham Acupuncture treatment)

Not yet recruiting
  • Hot Flashes
  • +2 more
  • Acupuncture treatment
  • Sham Acupuncture treatment
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital of Traditional Chinese Medcine
Jul 19, 2022

Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,

Not yet recruiting
  • Locoregional Recurrence
  • +2 more
  • (no location specified)
Jul 18, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Breast Cancer Female, Hormone-receptor-positive Breast Cancer Trial in Lisboa (Brief Physical Activity Counselling, Structured

Recruiting
  • Breast Cancer Female
  • Hormone-receptor-positive Breast Cancer
  • Brief Physical Activity Counselling
  • Structured Exercise Program
  • Lisboa, Portugal
    Universidade Lusófona, Campo Grande 376
May 5, 2023

Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

Active, not recruiting
  • Hormone-receptor-positive Breast Cancer
  • +2 more
  • No drug
  • Cambridge, Massachusetts
    ConcertAI database
Sep 8, 2023

Breast Cancer Trial in Boston (Eribulin Mesylate, Pembrolizumab)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Apr 18, 2022

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Hormone Receptor-positive Breast Cancer Trial (LACUDY)

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • (no location specified)
Dec 6, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial

Withdrawn
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +28 more
  • Carbon Dioxide Fractional Laser
  • Questionnaire Administration
  • (no location specified)
Jan 5, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Hormone Receptor Positive Malignant Tumor of Breast Trial in United States (RAD140)

Completed
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • New Haven, Connecticut
  • +4 more
Aug 16, 2022

Study of Screening Brain MRIs in Stage IV Breast Cancer

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Magnetic Resonance Imaging
  • Tampa, Florida
    Moffitt Cancer Center
Sep 30, 2022

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Breast Cancer Trial in Dallas (Letrozole, Abemaciclib)

Recruiting
  • Breast Cancer
  • Dallas, Texas
  • +1 more
Sep 30, 2022